Association Between Lipoprotein Subfractions, Hemostatic Potentials, and Coronary Atherosclerosis

Overview

Journal Dis Markers

Publisher Wiley

Specialty Biochemistry

Date 2022 Sep 9

PMID 36082237

Authors

Tadeja Poropat Flerin

Mojca Bozic Mijovski

Borut Jug

Affiliations

Soon will be listed here.

Abstract

Background: Dyslipidemias are associated with atherosclerotic plaque formation and a prothrombotic state, thus increasing the risk of both atherosclerotic vascular disease and atherothrombotic adverse events. We sought to explore the association between lipoprotein subfractions, overall hemostasis, and coronary calcifications in individuals at intermediate cardiovascular risk.

Methods: Consecutive statin-naive individuals at intermediate cardiovascular risk referred for coronary artery calcium score (CACS) scanning were included. CACS was assessed using a 128-slice dual-source CT scanner. Traditional lipid profile, high-density lipoprotein (HDL) subfractions 2 and 3, and small dense low-density lipoproteins (sdLDL) were measured with commercially available assays. Overall hemostatic (OHP) and coagulation potentials (OCP) were measured spectrophotometrically, using fibrin aggregation curves after exposure to thrombin and recombinant tissue-type plasminogen activator, respectively. Overall fibrinolytic potential (OFP) was calculated as a difference between the two areas under curves.

Results: We included 160 patients (median age 63 (interquartile range (IQR), 56-71 years, 52% women, and median CACS 8, IQR 0-173 Agatston units). HDL3 levels-but not sdLDL or hemostatic potentials-were significantly associated with CACS zero, even after adjusting for age, sex, arterial hypertension, dyslipidemia, diabetes, and smoking history (OR 0.980 (0.962-0.999), = 0.034). HDL3 was also significantly associated with OCP ( = -0.232, adjusted for age and sex 0.037).

Conclusions: In patients at intermediate cardiovascular risk, HDL3 is associated with both subclinical atherosclerosis and overall coagulation. Our findings are in line with studies reporting on an inverse relationship between HDL3 and atherosclerosis and provide one possible mechanistic explanation for the association between novel lipid biomarkers and coagulation derangements.

Citing Articles

Roxb. Leaves Ethanol Extract Ameliorates Lipid and Proinflammatory Cytokines Profiles in a Rat Model of Dyslipidemia.

Lumbanraja M, Anggadiredja K, Kurniati N, Muhammad H J Pharmacopuncture. 2024; 27(2):101-109.

PMID: 38948314 PMC: 11194525. DOI: 10.3831/KPI.2024.27.2.101.

Small dense low-density lipoprotein cholesterol and coronary artery calcification in the Multi-Ethnic Study of Atherosclerosis.

Rikhi R, Schaich C, Hafzalla G, Patel N, Tannenbaum J, German C Eur J Prev Cardiol. 2024; 31(8):1048-1054.

PMID: 38323698 PMC: 11144463. DOI: 10.1093/eurjpc/zwae049.

Epidemic trends of dyslipidemia in young adults: a real-world study including more than 20,000 samples.

Liu L, Aimaiti X, Zheng Y, Zhi X, Wang Z, Yin X Lipids Health Dis. 2023; 22(1):108.

PMID: 37516842 PMC: 10386655. DOI: 10.1186/s12944-023-01876-2.

References

Tian L, Li C, Liu Y, Chen Y, Fu M . The value and distribution of high-density lipoprotein subclass in patients with acute coronary syndrome. PLoS One. 2014; 9(1):e85114. PMC: 3900409. DOI: 10.1371/journal.pone.0085114. View

Borissoff J, Joosen I, Versteylen M, Spronk H, Ten Cate H, Hofstra L . Accelerated in vivo thrombin formation independently predicts the presence and severity of CT angiographic coronary atherosclerosis. JACC Cardiovasc Imaging. 2012; 5(12):1201-10. DOI: 10.1016/j.jcmg.2012.01.023. View

Norata G, Callegari E, Marchesi M, Chiesa G, Eriksson P, Catapano A . High-density lipoproteins induce transforming growth factor-beta2 expression in endothelial cells. Circulation. 2005; 111(21):2805-11. DOI: 10.1161/CIRCULATIONAHA.104.472886. View

Sampson U, Fazio S, Linton M . Residual cardiovascular risk despite optimal LDL cholesterol reduction with statins: the evidence, etiology, and therapeutic challenges. Curr Atheroscler Rep. 2011; 14(1):1-10. PMC: 3697085. DOI: 10.1007/s11883-011-0219-7. View

Moriyama K, Negami M, Takahashi E . HDL2-cholesterol/HDL3-cholesterol ratio was associated with insulin resistance, high-molecular-weight adiponectin, and components for metabolic syndrome in Japanese. Diabetes Res Clin Pract. 2014; 106(2):360-5. DOI: 10.1016/j.diabres.2014.08.007. View

He S, Antovic A, Blomback M . A simple and rapid laboratory method for determination of haemostasis potential in plasma. II. Modifications for use in routine laboratories and research work. Thromb Res. 2001; 103(5):355-61. DOI: 10.1016/s0049-3848(01)00332-2. View

Shah A, Tan L, Long J, Davidson W . Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond. J Lipid Res. 2013; 54(10):2575-85. PMC: 3770071. DOI: 10.1194/jlr.R035725. View

Rye K, Bursill C, Lambert G, Tabet F, Barter P . The metabolism and anti-atherogenic properties of HDL. J Lipid Res. 2008; 50 Suppl:S195-200. PMC: 2674714. DOI: 10.1194/jlr.R800034-JLR200. View

Agatston A, Janowitz W, HILDNER F, Zusmer N, VIAMONTE Jr M, Detrano R . Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990; 15(4):827-32. DOI: 10.1016/0735-1097(90)90282-t. View

10.

Willeit P, Thompson A, Aspelund T, Rumley A, Eiriksdottir G, Lowe G . Hemostatic factors and risk of coronary heart disease in general populations: new prospective study and updated meta-analyses. PLoS One. 2013; 8(2):e55175. PMC: 3567058. DOI: 10.1371/journal.pone.0055175. View

11.

Blann A, Burrows G, McCollum C . Oxidised and native low-density lipoproteins induce the release of von Willebrand factor from human endothelial cells in vitro. Br J Biomed Sci. 2003; 60(3):155-60. DOI: 10.1080/09674845.2003.11783693. View

12.

Ouweneel A, Van Eck M . Lipoproteins as modulators of atherothrombosis: From endothelial function to primary and secondary coagulation. Vascul Pharmacol. 2015; 82:1-10. DOI: 10.1016/j.vph.2015.10.009. View

13.

Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F . Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004; 364(9438):937-52. DOI: 10.1016/S0140-6736(04)17018-9. View

14.

Wadham C, Albanese N, Roberts J, Wang L, Bagley C, Gamble J . High-density lipoproteins neutralize C-reactive protein proinflammatory activity. Circulation. 2004; 109(17):2116-22. DOI: 10.1161/01.CIR.0000127419.45975.26. View

15.

Deguchi H, Elias D, Griffin J . Minor Plasma Lipids Modulate Clotting Factor Activities and May Affect Thrombosis Risk. Res Pract Thromb Haemost. 2017; 1(1):93-102. PMC: 5658053. DOI: 10.1002/rth2.12017. View

16.

Joshi P, Toth P, Lirette S, Griswold M, Massaro J, Martin S . Association of high-density lipoprotein subclasses and incident coronary heart disease: The Jackson Heart and Framingham Offspring Cohort Studies. Eur J Prev Cardiol. 2014; 23(1):41-9. PMC: 4312248. DOI: 10.1177/2047487314543890. View

17.

Poredos P, Cifkova R, Maier J, Nemcsik J, Sabovic M, Jug B . Preclinical atherosclerosis and cardiovascular events: Do we have a consensus about the role of preclinical atherosclerosis in the prediction of cardiovascular events?. Atherosclerosis. 2022; 348:25-35. DOI: 10.1016/j.atherosclerosis.2022.03.030. View

18.

Boren J, Chapman M, Krauss R, Packard C, Bentzon J, Binder C . Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2020; 41(24):2313-2330. PMC: 7308544. DOI: 10.1093/eurheartj/ehz962. View

19.

Mineo C, Deguchi H, Griffin J, Shaul P . Endothelial and antithrombotic actions of HDL. Circ Res. 2006; 98(11):1352-64. DOI: 10.1161/01.RES.0000225982.01988.93. View

20.

Kim J, Kim J, Song S, Kim H . Influence of blood lipids on global coagulation test results. Ann Lab Med. 2015; 35(1):15-21. PMC: 4272949. DOI: 10.3343/alm.2015.35.1.15. View